Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC Plus autologous stem-cell support: still very long survival but late relapses do occur (vol 158, pg 355, 2012)

Geisler Christian H<sup>*</sup>; Kolstad Arne; Laurell Anna; Jerkeman Mats; Raty Riikka; Andersen Niels S; Pedersen Lone B; Eriksson Mikael; Nordstrom Marie; Kimby Eva; Bentzen Hans; Kuittinen Outi; Lauritzsen Grete F; Nilsson Ehle Herman; Ralfkiaer Elisabeth; Ehinger Mats; Sundstrom Christer; Delabie Jan; Karjalainen Lind**erg Marja Liisa; Brown Peter; Elonen Erkki

doi:10.1111/bjh.12006

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC Plus autologous stem-cell support: still very long survival but late relapses do occur (vol 158, pg 355, 2012)

作者：Geisler Christian H^*; Kolstad Arne; Laurell Anna; Jerkeman Mats; Raty Riikka; Andersen Niels S; Pedersen Lone B; Eriksson Mikael; Nordstrom Marie; Kimby Eva; Bentzen Hans; Kuittinen Outi; Lauritzsen Grete F; Nilsson Ehle Herman; Ralfkiaer Elisabeth; Ehinger Mats; Sundstrom Christer; Delabie Jan; Karjalainen Lind**erg Marja Liisa; Brown Peter; Elonen Erkki

来源：British Journal of Haematology, 2012, 158(6): 815-816.

DOI：10.1111/bjh.12006